| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69ece09bafee7e0c49d1f7951a3faa2c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-4291
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-42 |
| filingDate |
2013-01-30^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_edbcc5bbb209973fb0531498459b2c9f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c8cc29e34890db096a80ebdf55188eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c60d91f171768c572579302924e2279
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53cd8c00d910413770bd3ce7d8ff0b11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_487365adc458f7a45740a8e11f18e8ce |
| publicationDate |
2014-12-10^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2809684-A1 |
| titleOfInvention |
Anti-ig-e m1' antibodies and methods using same |
| abstract |
This invention provides anti-IgE antibodies that bind to the M1' segment of a human IgE and their use in treating and preventing IgE-mediated disorders, as well as kits comprising the anti-IgE antibodies. |
| priorityDate |
2012-01-31^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |